1.10
price down icon8.33%   -0.10
 
loading

Pyxis Oncology Inc Azioni (PYXS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
16.15
- - - -
Cost Of Revenue
0.475
- - - -
Gross Profit
15.67
- - - -
Operating Expenses
19.75%
21.28
17.77 25.35 18.12 20.95
Benefits Costs and Expenses
19.40
- - - -
Costs And Expenses
19.40
- - - -
Operating Income/Loss
68.45%
-5.605
-17.77 -25.35 -18.12 -20.95
Nonoperating Income/Loss
8.25%
2.349
2.17 2.305 2.22 1.711
Income/Loss From Continuing Operations Before Tax
79.12%
-3.256
-15.60 -23.05 -15.90 -19.24
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
79.12%
-3.256
-15.60 -23.05 -15.90 -19.24
Net Income/Loss
79.12%
-3.256
-15.60 -23.05 -15.90 -19.24
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,263%
51.29
1.5252 41.33 38.39 35.35
Diluted Average Shares
3,263%
51.29
1.5252 41.33 38.39 35.35
Basic Earnings Per Share
81.82%
-0.06
-0.33 -0.56 -0.41 -0.54
Diluted Earnings Per Share
81.82%
-0.06
-0.33 -0.56 -0.41 -0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Capitalizzazione:     |  Volume (24 ore):